Open1.980 | Close2.000 |
Vol / Avg.42.821K / 20.227K | Mkt Cap57.622M |
Day Range1.960 - 2.000 | 52 Wk Range1.120 - 2.400 |
Dyadic International Stock (NASDAQ: DYAI) stock price, news, charts, stock research, profile.
Open1.980 | Close2.000 |
Vol / Avg.42.821K / 20.227K | Mkt Cap57.622M |
Day Range1.960 - 2.000 | 52 Wk Range1.120 - 2.400 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.050 | -0.070 | -0.0200 | ||||
REV | 1.300M | 837.159K | -462.841K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-24 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-02-03 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
2022-07-18 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-04-05 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 7.00 | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DYAI | Dyadic International | 1.01% | 57.6M |
OTLK | Outlook Therapeutics | -0.29% | 54.4M |
HOOK | HOOKIPA Pharma | -1.51% | 50.4M |
CRIS | Curis | -0.55% | 53M |
INTS | Intensity Therapeutics | 0.27% | 50.4M |
You can purchase shares of Dyadic International (NASDAQ: DYAI) through any online brokerage.
Other companies in Dyadic International’s space includes: Outlook Therapeutics (NASDAQ:OTLK), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Elicio Therapeutics (NASDAQ:ELTX).
The latest price target for Dyadic International (NASDAQ: DYAI) was reported by HC Wainwright & Co. on Wednesday, May 24, 2023. The analyst firm set a price target for 6.00 expecting DYAI to rise to within 12 months (a possible 200.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Dyadic International (NASDAQ: DYAI) is $2 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dyadic International.
Dyadic International’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Dyadic International.
Dyadic International is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dyadic International Stock (NASDAQ: DYAI) stock price, news, charts, stock research, profile.
Open1.980 | Close2.000 |
Vol / Avg.42.821K / 20.227K | Mkt Cap57.622M |
Day Range1.960 - 2.000 | 52 Wk Range1.120 - 2.400 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.050 | -0.070 | -0.0200 | ||||
REV | 1.300M | 837.159K | -462.841K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-24 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-02-03 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
2022-07-18 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-04-05 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 7.00 | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DYAI | Dyadic International | 1.01% | 57.6M |
OTLK | Outlook Therapeutics | -0.29% | 54.4M |
HOOK | HOOKIPA Pharma | -1.51% | 50.4M |
CRIS | Curis | -0.55% | 53M |
INTS | Intensity Therapeutics | 0.27% | 50.4M |
You can purchase shares of Dyadic International (NASDAQ: DYAI) through any online brokerage.
Other companies in Dyadic International’s space includes: Outlook Therapeutics (NASDAQ:OTLK), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Elicio Therapeutics (NASDAQ:ELTX).
The latest price target for Dyadic International (NASDAQ: DYAI) was reported by HC Wainwright & Co. on Wednesday, May 24, 2023. The analyst firm set a price target for 6.00 expecting DYAI to rise to within 12 months (a possible 200.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Dyadic International (NASDAQ: DYAI) is $2 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dyadic International.
Dyadic International’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Dyadic International.
Dyadic International is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dyadic International Stock (NASDAQ: DYAI) stock price, news, charts, stock research, profile.
Open1.980 | Close2.000 |
Vol / Avg.42.821K / 20.227K | Mkt Cap57.622M |
Day Range1.960 - 2.000 | 52 Wk Range1.120 - 2.400 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.050 | -0.070 | -0.0200 | ||||
REV | 1.300M | 837.159K | -462.841K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-24 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-02-03 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
2022-07-18 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-04-05 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 7.00 | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DYAI | Dyadic International | 1.01% | 57.6M |
OTLK | Outlook Therapeutics | -0.29% | 54.4M |
HOOK | HOOKIPA Pharma | -1.51% | 50.4M |
CRIS | Curis | -0.55% | 53M |
INTS | Intensity Therapeutics | 0.27% | 50.4M |
You can purchase shares of Dyadic International (NASDAQ: DYAI) through any online brokerage.
Other companies in Dyadic International’s space includes: Outlook Therapeutics (NASDAQ:OTLK), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Elicio Therapeutics (NASDAQ:ELTX).
The latest price target for Dyadic International (NASDAQ: DYAI) was reported by HC Wainwright & Co. on Wednesday, May 24, 2023. The analyst firm set a price target for 6.00 expecting DYAI to rise to within 12 months (a possible 200.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Dyadic International (NASDAQ: DYAI) is $2 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dyadic International.
Dyadic International’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Dyadic International.
Dyadic International is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dyadic International Stock (NASDAQ: DYAI) stock price, news, charts, stock research, profile.
Open1.980 | Close2.000 |
Vol / Avg.42.821K / 20.227K | Mkt Cap57.622M |
Day Range1.960 - 2.000 | 52 Wk Range1.120 - 2.400 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.050 | -0.070 | -0.0200 | ||||
REV | 1.300M | 837.159K | -462.841K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-24 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-02-03 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
2022-07-18 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-04-05 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 7.00 | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DYAI | Dyadic International | 1.01% | 57.6M |
OTLK | Outlook Therapeutics | -0.29% | 54.4M |
HOOK | HOOKIPA Pharma | -1.51% | 50.4M |
CRIS | Curis | -0.55% | 53M |
INTS | Intensity Therapeutics | 0.27% | 50.4M |
You can purchase shares of Dyadic International (NASDAQ: DYAI) through any online brokerage.
Other companies in Dyadic International’s space includes: Outlook Therapeutics (NASDAQ:OTLK), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Elicio Therapeutics (NASDAQ:ELTX).
The latest price target for Dyadic International (NASDAQ: DYAI) was reported by HC Wainwright & Co. on Wednesday, May 24, 2023. The analyst firm set a price target for 6.00 expecting DYAI to rise to within 12 months (a possible 200.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Dyadic International (NASDAQ: DYAI) is $2 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dyadic International.
Dyadic International’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Dyadic International.
Dyadic International is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dyadic International Stock (NASDAQ: DYAI) stock price, news, charts, stock research, profile.
Open1.980 | Close2.000 |
Vol / Avg.42.821K / 20.227K | Mkt Cap57.622M |
Day Range1.960 - 2.000 | 52 Wk Range1.120 - 2.400 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.050 | -0.070 | -0.0200 | ||||
REV | 1.300M | 837.159K | -462.841K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-24 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-02-03 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
2022-07-18 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-04-05 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 7.00 | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DYAI | Dyadic International | 1.01% | 57.6M |
OTLK | Outlook Therapeutics | -0.29% | 54.4M |
HOOK | HOOKIPA Pharma | -1.51% | 50.4M |
CRIS | Curis | -0.55% | 53M |
INTS | Intensity Therapeutics | 0.27% | 50.4M |
You can purchase shares of Dyadic International (NASDAQ: DYAI) through any online brokerage.
Other companies in Dyadic International’s space includes: Outlook Therapeutics (NASDAQ:OTLK), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Elicio Therapeutics (NASDAQ:ELTX).
The latest price target for Dyadic International (NASDAQ: DYAI) was reported by HC Wainwright & Co. on Wednesday, May 24, 2023. The analyst firm set a price target for 6.00 expecting DYAI to rise to within 12 months (a possible 200.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Dyadic International (NASDAQ: DYAI) is $2 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dyadic International.
Dyadic International’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Dyadic International.
Dyadic International is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dyadic International Stock (NASDAQ: DYAI) stock price, news, charts, stock research, profile.
Open1.980 | Close2.000 |
Vol / Avg.42.821K / 20.227K | Mkt Cap57.622M |
Day Range1.960 - 2.000 | 52 Wk Range1.120 - 2.400 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.050 | -0.070 | -0.0200 | ||||
REV | 1.300M | 837.159K | -462.841K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-24 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-02-03 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
2022-07-18 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-04-05 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 7.00 | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DYAI | Dyadic International | 1.01% | 57.6M |
OTLK | Outlook Therapeutics | -0.29% | 54.4M |
HOOK | HOOKIPA Pharma | -1.51% | 50.4M |
CRIS | Curis | -0.55% | 53M |
INTS | Intensity Therapeutics | 0.27% | 50.4M |
You can purchase shares of Dyadic International (NASDAQ: DYAI) through any online brokerage.
Other companies in Dyadic International’s space includes: Outlook Therapeutics (NASDAQ:OTLK), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Elicio Therapeutics (NASDAQ:ELTX).
The latest price target for Dyadic International (NASDAQ: DYAI) was reported by HC Wainwright & Co. on Wednesday, May 24, 2023. The analyst firm set a price target for 6.00 expecting DYAI to rise to within 12 months (a possible 200.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Dyadic International (NASDAQ: DYAI) is $2 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dyadic International.
Dyadic International’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Dyadic International.
Dyadic International is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dyadic International Stock (NASDAQ: DYAI) stock price, news, charts, stock research, profile.
Open1.980 | Close2.000 |
Vol / Avg.42.821K / 20.227K | Mkt Cap57.622M |
Day Range1.960 - 2.000 | 52 Wk Range1.120 - 2.400 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.050 | -0.070 | -0.0200 | ||||
REV | 1.300M | 837.159K | -462.841K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-24 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-02-03 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
2022-07-18 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-04-05 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 7.00 | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DYAI | Dyadic International | 1.01% | 57.6M |
OTLK | Outlook Therapeutics | -0.29% | 54.4M |
HOOK | HOOKIPA Pharma | -1.51% | 50.4M |
CRIS | Curis | -0.55% | 53M |
INTS | Intensity Therapeutics | 0.27% | 50.4M |
You can purchase shares of Dyadic International (NASDAQ: DYAI) through any online brokerage.
Other companies in Dyadic International’s space includes: Outlook Therapeutics (NASDAQ:OTLK), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Elicio Therapeutics (NASDAQ:ELTX).
The latest price target for Dyadic International (NASDAQ: DYAI) was reported by HC Wainwright & Co. on Wednesday, May 24, 2023. The analyst firm set a price target for 6.00 expecting DYAI to rise to within 12 months (a possible 200.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Dyadic International (NASDAQ: DYAI) is $2 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dyadic International.
Dyadic International’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Dyadic International.
Dyadic International is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dyadic International Stock (NASDAQ: DYAI) stock price, news, charts, stock research, profile.
Open1.980 | Close2.000 |
Vol / Avg.42.821K / 20.227K | Mkt Cap57.622M |
Day Range1.960 - 2.000 | 52 Wk Range1.120 - 2.400 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.050 | -0.070 | -0.0200 | ||||
REV | 1.300M | 837.159K | -462.841K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-24 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-02-03 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
2022-07-18 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-04-05 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 7.00 | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DYAI | Dyadic International | 1.01% | 57.6M |
OTLK | Outlook Therapeutics | -0.29% | 54.4M |
HOOK | HOOKIPA Pharma | -1.51% | 50.4M |
CRIS | Curis | -0.55% | 53M |
INTS | Intensity Therapeutics | 0.27% | 50.4M |
You can purchase shares of Dyadic International (NASDAQ: DYAI) through any online brokerage.
Other companies in Dyadic International’s space includes: Outlook Therapeutics (NASDAQ:OTLK), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Elicio Therapeutics (NASDAQ:ELTX).
The latest price target for Dyadic International (NASDAQ: DYAI) was reported by HC Wainwright & Co. on Wednesday, May 24, 2023. The analyst firm set a price target for 6.00 expecting DYAI to rise to within 12 months (a possible 200.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Dyadic International (NASDAQ: DYAI) is $2 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dyadic International.
Dyadic International’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Dyadic International.
Dyadic International is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dyadic International Stock (NASDAQ: DYAI) stock price, news, charts, stock research, profile.
Open1.980 | Close2.000 |
Vol / Avg.42.821K / 20.227K | Mkt Cap57.622M |
Day Range1.960 - 2.000 | 52 Wk Range1.120 - 2.400 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.050 | -0.070 | -0.0200 | ||||
REV | 1.300M | 837.159K | -462.841K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-24 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-02-03 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
2022-07-18 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-04-05 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 7.00 | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DYAI | Dyadic International | 1.01% | 57.6M |
OTLK | Outlook Therapeutics | -0.29% | 54.4M |
HOOK | HOOKIPA Pharma | -1.51% | 50.4M |
CRIS | Curis | -0.55% | 53M |
INTS | Intensity Therapeutics | 0.27% | 50.4M |
You can purchase shares of Dyadic International (NASDAQ: DYAI) through any online brokerage.
Other companies in Dyadic International’s space includes: Outlook Therapeutics (NASDAQ:OTLK), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Elicio Therapeutics (NASDAQ:ELTX).
The latest price target for Dyadic International (NASDAQ: DYAI) was reported by HC Wainwright & Co. on Wednesday, May 24, 2023. The analyst firm set a price target for 6.00 expecting DYAI to rise to within 12 months (a possible 200.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Dyadic International (NASDAQ: DYAI) is $2 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dyadic International.
Dyadic International’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Dyadic International.
Dyadic International is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.